Statins
Sort by:
Complex Coronary Cases
Role of Triglycerides & More
FEATURING
Robert Rosenson
- 2,762 views
- August 31, 2023
- 16
The Texas Heart Institute
Non-Statin Therapies for LDL-C Lowering: How to Rationally Use Them?
FEATURING
Salim Virani
- 2,197 views
- November 12, 2021
- 15
Canadian Collaborative Research Network
The Disruptive Science of LDL-Lowering: From Statins to PCSK9 Manipulation
FEATURING
Milan Gupta
- 1,561 views
- May 14, 2024
- 13
Michigan Medicine
Updates in Lipid Management
FEATURING
Scott L. Hummel
- 1,821 views
- August 28, 2024
- 14
Scripps Health
Non-Statin Pharmacotherapies for Risk Reduction
FEATURING
Michael Wilkinson
- 3,421 views
- June 28, 2022
- 13
Cardiometabolic Health Congress (CMHC)
ASCVD Risk Assessment and Prevention: Where Do We Stand Now?
FEATURING
Salim Virani
- 1,174 views
- July 23, 2022
- 13
Cleveland Clinic Heart, Vascular and Thoracic Institute
Heart Outcomes Prevention Evaluation–3 - HOPE-3 Trial
FEATURING
Steven Nissen
- 1,771 views
- July 26, 2016
- 13
Keck School of Medicine of USC
Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?
FEATURING
Steven Nissen
- 947 views
- January 5, 2021
- 13
Complex Coronary Cases
Eliminating Coronary Artery Disease
FEATURING
Marc Sabatine
- 1,193 views
- August 31, 2023
- 10
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Defining and Treating Dyslipidemia
FEATURING
Michael J. Wilkinson
- 1,446 views
- March 6, 2024
- 11
The Texas Heart Institute
The Use of Coronary Artery Calcium Score to Determine Benefit of Aspirin Therapy
FEATURING
Eduardo Hernandez
- 1,144 views
- November 12, 2021
- 11
Canadian Collaborative Research Network
Has the Time Come to Treat Inflammation to Improve Cardiovascular Outcomes? (Yes!)
FEATURING
Paul Ridker
- 1,408 views
- July 26, 2023
- 10
National Lipid Association
Pearls from 34 Years of Running a Lipid Clinic
FEATURING
Alan Brown
- 1,161 views
- March 25, 2019
- 11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 924 views
- February 5, 2021
- 11
Houston Methodist DeBakey Heart and Vascular Center
Update on Inflammation & Atherosclerosis Treatment: Should All Atherosclerosis Patients Receive Aggressive Lipid-Lowering and Inflammation Inhibiting Therapy? Why Not Combine Anti-Inflammatory Therapy with PCSK9 Inhibition?
FEATURING
Paul Ridker
- 1,523 views
- July 14, 2020
- 9
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,155 views
- December 3, 2017
- 8
The Texas Heart Institute
Updates in Guidelines for the Management of Chronic Coronary Artery Disease: What We Should Pay Closer Attention To
FEATURING
Salim Virani
- 913 views
- March 15, 2024
- 10
Scripps Health
Master Class on LDL-C, LP(a), and Non-HDL: How Low to Go?
FEATURING
Douglas Triffon
- 1,412 views
- July 3, 2024
- 10
Penn Medicine Heart and Vascular Center
Lipoprotein(a) and Cardiovascular Risks: New Insights
FEATURING
Vera Bittner
- 2,059 views
- December 19, 2023
- 10
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk
FEATURING
Patrick Moriarty
- 834 views
- August 10, 2018
- 10
Top Ten Topics in Clinical Cardiology 2022
What’ll be New in Lipid Management in 2023? Rethinking the Paradigms
FEATURING
Robert Rosenson
- 3,192 views
- November 21, 2022
- 10